BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5211728)

  • 21. [Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
    Speranskaia ON; Fomina IP; Kuznetsova SM
    Antibiotiki; 1973 Jan; 18(1):62-8. PubMed ID: 4486587
    [No Abstract]   [Full Text] [Related]  

  • 22. Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Aug; 91(4):279-84. PubMed ID: 6556002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
    Chandrasekar PH; Sluchak JA
    Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and laboratory studies of nosocomial Staphylococcus aureus resistant to methicillin and aminoglycosides.
    Bock BV; Pasiecznik K; Meyer RD
    Infect Control; 1982; 3(3):224-8. PubMed ID: 6920362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    Lancet; 1989 Mar; 1(8637):537-40. PubMed ID: 2564067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies.
    Ridley M; Lynn R; Barrie D; Stead KC
    Lancet; 1970 Jan; 1(7640):230-3. PubMed ID: 4189020
    [No Abstract]   [Full Text] [Related]  

  • 29. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological indications for the treatment of Staphylococcus aureus infections.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.
    Lowy FD; Walsh JA; Mayers MM; Klein RS; Steigbigel NH
    Antimicrob Agents Chemother; 1979 Sep; 16(3):314-21. PubMed ID: 259421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections: vancomycin update.
    Gennery BA; Cooper GL
    Br J Clin Pract Suppl; 1988 Feb; 57():100-1. PubMed ID: 3140867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 37. An outbreak of infection with a gentamicin and methicillin-resistant Staphylococcus aureus in a neonatal unit.
    Price EH; Brain A; Dickson JA
    J Hosp Infect; 1980 Sep; 1(3):221-8. PubMed ID: 6182215
    [No Abstract]   [Full Text] [Related]  

  • 38. Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin.
    Shanson DC; Kensit JC; Duke R
    Lancet; 1976 Dec; 2(7999):1347-8. PubMed ID: 63814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.